FDA Drug Recalls

Recalls / Class III

Class IIID-0198-2026

Product

Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17.

Brand name
Testosterone
Generic name
Testosterone
Active ingredient
Testosterone
Route
Topical
NDCs
0591-2921, 0591-3216, 0591-3217
FDA application
ANDA076737
Affected lot / code info
Lot #100068692, Exp.: 04/30/2027

Why it was recalled

Defective Container - A defect in the side-seal which allows leakage of product.

Recalling firm

Firm
Teva Pharmaceuticals USA, Inc
Manufacturer
Actavis Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
400 Interpace Pkwy Bldg A, Parsippany, New Jersey 07054-1120

Distribution

Quantity
15,944 cartons
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2025-11-07
FDA classified
2025-12-01
Posted by FDA
2025-12-10
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0198-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.